Diagnosis and Management of Inflammatory and Infectious Diseases

NCT00557726 | Recruiting

• 2 other identifiers: 78002378-I-0023
• Study Type: observational
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

This protocol is being established to cover the evaluation of patients with inflammatory and/or infectious diseases which are not covered under previously existing protocols. The purpose of such a protocol is that frequently patients are referred to us with either diagnosed or undiagnosed illnesses which would be of interest to our teaching program or which would serve as a source of patients to subsequently be entered into established, ongoing protocol studies. Such patients will be admitted to the protocol and handled according to accepted medical practice of diagnosis and treatment.

Conditions

Infection; Inflammation

Keywords

Inflammation; Infection; Fever; Natural History

Outcome Measures

Primary Outcomes (1)

• H&P, labs and other clinical metrics

  this is a hypothesis-generating training consult protocol

  initial and follow-up clinic visits

Study Arms (1)

1

Patients with a variety of infections and inflammatory diseases.

Eligibility Criteria

• Age: 3 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Individuals with an inflammatory or infectious condition are evaluated.

You may qualify if:

• Known or suspected exposure to infection, as determined by the Principal Investigator OR Presence of signs and symptoms of an infectious or inflammatory disease
• Age range: 3 years of age and older.
• NIAID/LIR investigator who has an interest in the patient s illness and is willing to serve as attending physician to supervise the patient's medical care at the NIH.
• Primary physician outside the NIH
• The patient or the patient's Legally Authorized Representative is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18

You may not qualify if:

• Pregnant.
• Presence of conditions that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.

Sponsors & Collaborators

• National Institute of Allergy and Infectious Diseases (NIAID): lead

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

RECRUITING

Related Links

• NIH Clinical Center Detailed Web Page

MeSH Terms

Conditions

Infections; Inflammation; Fever

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms; Body Temperature Changes; Signs and Symptoms

Study Officials

• Mary E Wright, M.D.

  National Institute of Allergy and Infectious Diseases (NIAID)

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Rosemary McConnell, R.N.

CONTACT

(301) 312-1235; rosemary.mcconnell@nih.gov

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 10, 2007
• First Posted: November 14, 2007
• Study Start: February 17, 1978
• Last Updated: April 30, 2026

Record last verified: 2026-04-23

Locations

US (1)